| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017665005 |
| P356 | DOI | 10.1038/SJ.ONC.1207293 |
| P698 | PubMed publication ID | 14647426 |
| P50 | author | Kevin R. Coombes | Q30505720 |
| P2093 | author name string | Timothy J McDonnell | |
| Christopher J Logothetis | |||
| David L Gold | |||
| Kevin B Spurgers | |||
| Raymond E Meyn | |||
| Terry J Johnson | |||
| P2860 | cites work | Covalent and noncovalent modifiers of the p53 protein | Q22009048 |
| p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53 | Q24290402 | ||
| p53 has a direct apoptogenic role at the mitochondria | Q24298888 | ||
| A model for p53-induced apoptosis | Q24313374 | ||
| Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 | Q24328775 | ||
| NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription | Q24600573 | ||
| UV Irradiation Stimulates Levels of p53 Cellular Tumor Antigen in Nontransformed Mouse Cells | Q24609948 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
| Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis | Q28144256 | ||
| Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway | Q28215330 | ||
| The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression | Q28277156 | ||
| The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation | Q28280958 | ||
| A protein related to a proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its 'death domain' | Q28292545 | ||
| p53 mutations in human cancers | Q28302973 | ||
| Rapid destruction of human Cdc25A in response to DNA damage | Q28611930 | ||
| Mammalian G1- and S-phase checkpoints in response to DNA damage | Q29013238 | ||
| Live or let die: the cell's response to p53 | Q29547663 | ||
| Cancer. p53, guardian of the genome | Q29615610 | ||
| The Bcl-2 protein family: arbiters of cell survival | Q29618158 | ||
| Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy | Q33633919 | ||
| BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity | Q33777930 | ||
| Death and decoy receptors and p53-mediated apoptosis. | Q33913737 | ||
| Bcl-2-related proteins and cancer | Q33929353 | ||
| Gene therapy for bladder cancer | Q33943113 | ||
| Does p53 status influence tumor response to anticancer therapies? | Q34042740 | ||
| The p53MH algorithm and its application in detecting p53-responsive genes | Q34064408 | ||
| Redox aspects of Bcl-2 function. | Q34169008 | ||
| The p53 and Mdm2 families in cancer. | Q34493139 | ||
| Role and function of the 26S proteasome in proliferation and apoptosis. | Q34785023 | ||
| Clinical update of Ad-p53 gene therapy for lung cancer | Q35027793 | ||
| Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells | Q35571910 | ||
| Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein | Q35755347 | ||
| Bcl-2 expression causes redistribution of glutathione to the nucleus | Q35975065 | ||
| Role of cysteine residues in regulation of p53 function | Q36552986 | ||
| Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function | Q36562198 | ||
| Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value | Q37730372 | ||
| The p53 tumour suppressor gene | Q37751892 | ||
| Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches | Q38296572 | ||
| Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x | Q38452930 | ||
| Redox state of tumor suppressor p53 regulates its sequence-specific DNA binding in DNA-damaged cells by cysteine 277 | Q39615561 | ||
| A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis | Q40019792 | ||
| TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2. | Q40794513 | ||
| Inhibition of p53 transcriptional activity by Bcl-2 requires its membrane-anchoring domain | Q40970925 | ||
| Inhibitory effect of Bcl-2 on p53-mediated transactivation following genotoxic stress | Q40976420 | ||
| Wild-type p53 negatively regulates the expression of a microtubule-associated protein | Q41148864 | ||
| Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. | Q41414258 | ||
| p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes | Q41454039 | ||
| The 26S proteasome: subunits and functions | Q41535632 | ||
| p53 oncogene mutations in three human prostate cancer cell lines | Q41586000 | ||
| p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. | Q41723055 | ||
| Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth | Q42121132 | ||
| Bcl-2 inhibits p53 nuclear import following DNA damage | Q42833464 | ||
| BCL-2 is involved in preventing oxidant-induced cell death and in decreasing oxygen radical production. | Q43897073 | ||
| Assessment of p53 gene transfer and biological activities in a clinical study of adenovirus-p53 gene therapy for recurrent ovarian cancer | Q44362471 | ||
| A novel form of Epstein-Barr virus latency in normal B cells in vivo | Q45789413 | ||
| Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results | Q45863348 | ||
| Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors | Q45869523 | ||
| A recombinant adenovirus expressing wild-type Bax induces apoptosis in prostate cancer cells independently of their Bcl-2 status and androgen sensitivity | Q45888474 | ||
| Bcl-2 family members inhibit oxidative stress-induced programmed cell death in Saccharomyces cerevisiae. | Q47939174 | ||
| Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma | Q47976180 | ||
| Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. | Q50335767 | ||
| Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation. | Q52190269 | ||
| Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition | Q53425055 | ||
| Induction of apoptosis in HeLa cells by trans-activation-deficient p53 | Q53461564 | ||
| Bcl-2 as a predictor of chemosensitivity and prognosis in primary epithelial ovarian cancer | Q54067329 | ||
| Superoxide dismutase as a target for the selective killing of cancer cells | Q59060864 | ||
| Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18) | Q59085244 | ||
| Mechanisms of p53-dependent apoptosis | Q63408390 | ||
| INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201 | Q64377713 | ||
| Molecular determinants of cell death induction following adenovirus-mediated gene transfer of wild-type p53 in prostate cancer cells | Q64380177 | ||
| Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes | Q68180257 | ||
| Safety evaluation of Ad5CMV-p53 in vitro and in vivo | Q72202236 | ||
| Bcl-2 accelerates multistep prostate carcinogenesis in vivo | Q73187748 | ||
| Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols | Q73794417 | ||
| Bcl-2 Suppresses Apoptosis Resulting from Disruption of the NF-κB Survival Pathway☆ | Q74000214 | ||
| Deletion of the Saccharomyces cerevisiae TRR1 Gene Encoding Thioredoxin Reductase Inhibits p53-dependent Reporter Gene Expression | Q74263605 | ||
| Essential role for caspase-8 in transcription-independent apoptosis triggered by p53 | Q74316975 | ||
| Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53 | Q77764263 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 1712-1723 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells | |
| P478 | volume | 23 |
| Q33983097 | A resource for discovering specific and universal biomarkers for distributed stem cells |
| Q38305680 | Dissecting functional roles of p53 N-terminal transactivation domains by microarray expression analysis |
| Q40439945 | Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation |
| Q91796711 | Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets |
| Q40263007 | Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repression |
| Q39570732 | PI3 Kinase inhibition on TRAIL-induced apoptosis correlates with androgen-sensitivity and p21 expression in prostate cancer cells |
| Q38805972 | Silencing overexpression of FXYD3 protein in breast cancer cells amplifies effects of doxorubicin and γ-radiation on Na(+)/K(+)-ATPase and cell survival |
| Q37145192 | The adenoviral E1B 55-kilodalton protein controls expression of immune response genes but not p53-dependent transcription |
| Q35919370 | The direct p53 target gene, FLJ11259/DRAM, is a member of a novel family of transmembrane proteins |
| Q40271317 | Up-regulation of Skp2 after prostate cancer cell adhesion to basement membranes results in BRCA2 degradation and cell proliferation |
Search more.